{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T06:01:19Z","timestamp":1772431279730,"version":"3.50.1"},"reference-count":40,"publisher":"American Diabetes Association","issue":"5","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:p>OBJECTIVE\u2014Cardiovascular disease (CVD) is the main cause of morbidity\/mortality in diabetes. We set forth to determine incidence and identify predictors (including microvascular complications and treatment) of first coronary heart disease (CHD) event in CVD-free type 2 diabetic patients.<\/jats:p>\n               <jats:p>RESEARCH DESIGN AND METHODS\u2014A cohort of 6,032 women and 5,612 men, sampled from a nationwide network of hospital-based diabetes clinics, was followed up for 4 years. Baseline assessment included retinopathy, nephropathy, and foot ulcers. First CHD events (myocardial infarction, coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, and electrocardiogram-proven angina) were analyzed for 29,069 person-years.<\/jats:p>\n               <jats:p>RESULTS\u2014The age-standardized incidence rate (per 1,000 person-years) of first CHD event (n = 881) was 28.8 (95% CI 5.4\u201332.2) in men and 23.3 (20.2\u201326.4) in women. Major CHD (myocardial infarction, coronary artery bypass grafting, and percutaneous transluminal coronary angioplasty) was less frequent in women (5.8 [4.3\u20137.2]) than in men (13.1 [10.9\u201315.4]; a sex ratio of 0.5 [0.4\u20130.6]). Incidence rates of all outcomes were higher in patients with microvascular complications (for major CHD, age-adjusted rate ratios were 1.6 [1.2\u20132.21] in men and 1.5 [1.0\u20132.2] in women). By multivariate Cox analysis, age and diabetes duration were risk predictors common in both sexes. In men, glycemic control and treated hypertension were additional independent risk factors, but residing in the south was associated with a significant 29% risk reduction. In women, higher triglycerides\/lower HDL cholesterol and microvascular complications were independent risk factors.<\/jats:p>\n               <jats:p>CONCLUSIONS\u2014In CVD-free patients with type 2 diabetes, risk of first CHD event depends on sex, geographic location, and presence of microvascular disease. Hyperglycemia and hypertension, particularly in men, and diabetic dyslipidemia, especially in women, are risk factors amenable to more aggressive treatment.<\/jats:p>","DOI":"10.2337\/dc06-2558","type":"journal-article","created":{"date-parts":[[2007,4,27]],"date-time":"2007-04-27T17:29:23Z","timestamp":1177694963000},"page":"1241-1247","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":123,"title":["Incidence of Coronary Heart Disease in Type 2 Diabetic Men and Women"],"prefix":"10.2337","volume":"30","author":[{"given":"Angelo","family":"Avogaro","sequence":"first","affiliation":[{"name":"Division of Metabolic Diseases, University of Padua, Padua, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Giorda","sequence":"additional","affiliation":[{"name":"Metabolism and Diabetes Unit, Regione Piemonte, Chieri, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Maggini","sequence":"additional","affiliation":[{"name":"National Institute of Health, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Mannucci","sequence":"additional","affiliation":[{"name":"University of Florence and Azienda Ospedaliera Careggi, Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Raschetti","sequence":"additional","affiliation":[{"name":"National Institute of Health, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Lombardo","sequence":"additional","affiliation":[{"name":"National Institute of Health, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Spila-Alegiani","sequence":"additional","affiliation":[{"name":"National Institute of Health, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Turco","sequence":"additional","affiliation":[{"name":"Federico II University, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Velussi","sequence":"additional","affiliation":[{"name":"Casa di Cura Pineta del Carso, Aurisina, Trieste, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, and C.N.R. Institute of Clinical Physiology, University of Pisa School of Medicine, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Diabetes and Informatics Study Group, Association of Clinical Diabetologists, Istituto Superiore di Sanita\u0300","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031220155608600_R1","doi-asserted-by":"crossref","unstructured":"Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, Connolly V, King H: The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care\u200828: 2130\u20132135, 2005","DOI":"10.2337\/diacare.28.9.2130"},{"key":"2022031220155608600_R2","doi-asserted-by":"crossref","unstructured":"Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA\u2008241:2035\u20132038, 1979","DOI":"10.1001\/jama.241.19.2035"},{"key":"2022031220155608600_R3","doi-asserted-by":"crossref","unstructured":"Fox CS, Sullivan L, D'Agostino RB Sr, Wilson PW: The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care\u200827:704\u2013708, 2004","DOI":"10.2337\/diacare.27.3.704"},{"key":"2022031220155608600_R4","doi-asserted-by":"crossref","unstructured":"Almdal T, Scharling H, Jensen JS, Vestergaard H: The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med\u2008164:1422\u20131426, 2004","DOI":"10.1001\/archinte.164.13.1422"},{"key":"2022031220155608600_R5","doi-asserted-by":"crossref","unstructured":"Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J, Multiple Risk Factor Intervention Trial Research Group: Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med\u2008164:1438\u20131443, 2004","DOI":"10.1001\/archinte.164.13.1438"},{"key":"2022031220155608600_R6","doi-asserted-by":"crossref","unstructured":"Fuller JH, Stevens LK, Wang SL: Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia\u200844(Suppl. 2):S54\u2013S64, 2001","DOI":"10.1007\/PL00002940"},{"key":"2022031220155608600_R7","doi-asserted-by":"crossref","unstructured":"Lee WL, Cheung AM, Cape D, Zinman B: Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care\u200823:962\u2013968, 2000","DOI":"10.2337\/diacare.23.7.962"},{"key":"2022031220155608600_R8","doi-asserted-by":"crossref","unstructured":"Huxley R, Barzi F, Woodward M: Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ\u2008332:73\u201378, 2006","DOI":"10.1136\/bmj.38678.389583.7C"},{"key":"2022031220155608600_R9","doi-asserted-by":"crossref","unstructured":"Kronmal RA, Barzilay JI, Tracy RP, Savage PJ, Orchard TJ, Burke GL: The relationship of fasting serum radioimmune insulin levels to incident coronary heart disease in an insulin-treated diabetic cohort. J Clin Endocrinol Metab\u200889:2582\u20132588, 2004","DOI":"10.1210\/jc.2003-031822"},{"key":"2022031220155608600_R10","doi-asserted-by":"crossref","unstructured":"Kronmal RA, Barzilay JI, Smith NL, Psaty BM, Kuller LH, Burke GL, Furberg C: Mortality in pharmacologically treated older adults with diabetes: the Cardiovascular Health Study, 1989\u20132001. PloS Med\u20083:e400, 2006","DOI":"10.1371\/journal.pmed.0030400"},{"key":"2022031220155608600_R11","doi-asserted-by":"crossref","unstructured":"Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET, the Strong Heart Investigators: Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. Diabetes Care\u200821:1258\u20131265, 1998","DOI":"10.2337\/diacare.21.8.1258"},{"key":"2022031220155608600_R12","doi-asserted-by":"crossref","unstructured":"Ruige JB, Assendelft WJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM: Insulin and risk of cardiovascular disease: a meta-analysis. Circulation\u200897:996\u20131001, 1998","DOI":"10.1161\/01.CIR.97.10.996"},{"key":"2022031220155608600_R13","doi-asserted-by":"crossref","unstructured":"Fox CS, Coady S, Sorlie PD, Levy D, Meigs JB, D'Agostino RB Sr, Wilson PW, Savage PJ: Trends in cardiovascular complications of diabetes. JAMA\u2008292:2495\u20132499, 2004","DOI":"10.1001\/jama.292.20.2495"},{"key":"2022031220155608600_R14","doi-asserted-by":"crossref","unstructured":"The DAI Study Group: Prevalence of coronary heart disease in a cohort of type 2 diabetic patients in Italy: the DAI study. Diabet Med\u200821:738\u2013745, 2004","DOI":"10.1111\/j.1464-5491.2004.01230.x"},{"key":"2022031220155608600_R15","doi-asserted-by":"crossref","unstructured":"D'Agostino RB Jr: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med\u200817:2265\u20132281, 1998","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B"},{"key":"2022031220155608600_R16","doi-asserted-by":"crossref","unstructured":"Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefebvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Koranyi L, Laakso M, Mokan M, Norkus A, Pirags V, Podar T, Scheen A, Sherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J, PROactive investigators: Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet\u2008366:1279\u20131289, 2005","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"2022031220155608600_R17","doi-asserted-by":"crossref","unstructured":"Koskinen P, Manttari M, Manninen V, Huttunen JK, Heinonen OP, Frick MH: Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care\u200815:820\u2013825, 1992","DOI":"10.2337\/diacare.15.7.820"},{"key":"2022031220155608600_R18","doi-asserted-by":"crossref","unstructured":"Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med\u2008339:229\u2013234, 1998","DOI":"10.1056\/NEJM199807233390404"},{"key":"2022031220155608600_R19","doi-asserted-by":"crossref","unstructured":"Lee CD, Folsom AR, Pankow JS, Brancati FL, Atherosclerosis Risk in Communities (ARIC) Study Investigators: Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation\u2008109:855\u2013860, 2004","DOI":"10.1161\/01.CIR.0000116389.61864.DE"},{"key":"2022031220155608600_R20","doi-asserted-by":"crossref","unstructured":"Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesaniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M, FIELD Study Investigators: Effects of long-term fenofibrate therapy on cardiovascular events in 9,795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet\u2008366:1849\u20131861, 2005","DOI":"10.1016\/S0140-6736(05)67667-2"},{"key":"2022031220155608600_R21","doi-asserted-by":"crossref","unstructured":"Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med\u2008141:421\u2013431, 2004","DOI":"10.7326\/0003-4819-141-6-200409210-00007"},{"key":"2022031220155608600_R22","doi-asserted-by":"crossref","unstructured":"Janssen F, Kunst AE: Cohort patterns in mortality trends among the elderly in seven European countries, 1950\u20131999. Int J Epidemiol\u200834:1149\u20131159, 2005","DOI":"10.1093\/ije\/dyi123"},{"key":"2022031220155608600_R23","doi-asserted-by":"crossref","unstructured":"Palmieri L, Donfrancesco C, Giampaoli S, Trojani M, Panico S, Vanuzzo D, Pilotto L, Cesana G, Ferrario M, Chiodini P, Sega R, Stamler J: Favorable cardiovascular risk profile and 10-year coronary heart disease incidence in women and men: results from the Progetto CUORE. Eur J Cardiovasc Prev Rehabil\u200813:562\u2013570, 2006","DOI":"10.1097\/01.hjr.0000221866.27039.4b"},{"key":"2022031220155608600_R24","doi-asserted-by":"crossref","unstructured":"Kanaya AM, Grady D, Barrett-Connor E: Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med\u2008162:1737\u20131745, 2002","DOI":"10.1001\/archinte.162.15.1737"},{"key":"2022031220155608600_R25","doi-asserted-by":"crossref","unstructured":"Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke\u200827:2033\u20132039, 1996","DOI":"10.1161\/01.STR.27.11.2033"},{"key":"2022031220155608600_R26","doi-asserted-by":"crossref","unstructured":"Mattock MB, Barnes DJ, Viberti G, Keen H, Burt D, Hughes JM, Fitzgerald AP, Sandhu B, Jackson PG: Microalbuminuria and coronary heart disease in NIDDM: an incidence study. Diabetes\u200847:1786\u20131792, 1998","DOI":"10.2337\/diabetes.47.11.1786"},{"key":"2022031220155608600_R27","doi-asserted-by":"crossref","unstructured":"Hiller R, Sperduto RD, Podgor MJ, Ferris FL 3rd, Wilson PW: Diabetic retinopathy and cardiovascular disease in type II diabetics: the Framingham Heart Study and the Framingham Eye Study. Am J Epidemiol\u2008128:402\u2013409, 1988","DOI":"10.1093\/oxfordjournals.aje.a114980"},{"key":"2022031220155608600_R28","doi-asserted-by":"crossref","unstructured":"Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Retinopathy predicts coronary heart disease events in MIDDM patients. Diabetes Care\u200819:1445\u20131448, 1996","DOI":"10.2337\/diacare.19.12.1445"},{"key":"2022031220155608600_R29","doi-asserted-by":"crossref","unstructured":"Peppa M, Uribarri J, Vlassara H: The role of advanced glycation end products in the development of atherosclerosis. Curr Diab Rep\u20084:31\u201336, 2004","DOI":"10.1007\/s11892-004-0008-6"},{"key":"2022031220155608600_R30","doi-asserted-by":"crossref","unstructured":"Madamanchi NR, Vendrov A, Runge MS: Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol\u200825:29\u201338, 2005","DOI":"10.1161\/01.ATV.0000150649.39934.13"},{"key":"2022031220155608600_R31","doi-asserted-by":"crossref","unstructured":"Scognamiglio R, Negut C, De Kreutzenberg SV, Tiengo A, Avogaro A: Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation\u2008112:179\u2013184, 2005","DOI":"10.1161\/CIRCULATIONAHA.104.495127"},{"key":"2022031220155608600_R32","unstructured":"Aras R, Sowers JR, Arora R: The proinflammatory and hypercoagulable state of diabetes mellitus. Rev Cardiovasc Med\u20086:84\u201397, 2005"},{"key":"2022031220155608600_R33","doi-asserted-by":"crossref","unstructured":"Nest RW: Correlation between cardiovascular disease and diabetes mellitus: current concepts. Am J Med\u2008116 (Suppl. 5A):11S\u201322S, 2004","DOI":"10.1016\/j.amjmed.2003.10.016"},{"key":"2022031220155608600_R34","doi-asserted-by":"crossref","unstructured":"Laakso M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes\u200848:937\u2013942, 1999","DOI":"10.2337\/diabetes.48.5.937"},{"key":"2022031220155608600_R35","doi-asserted-by":"crossref","unstructured":"Wang S-L, Head J, Stevens L, Fuller JH, WHO Multinational Study Group: Excess mortality and its relation to hypertension and proteinuria in diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care\u200819:305\u2013312, 1996","DOI":"10.2337\/diacare.19.4.305"},{"key":"2022031220155608600_R36","doi-asserted-by":"crossref","unstructured":"Lu W, Resnick HE, Jablonski KA, Jones KL, Jain AK, Howard WJ, Robbins DC, Howard BV: Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care\u200826:16\u201323, 2003","DOI":"10.2337\/diacare.26.1.16"},{"key":"2022031220155608600_R37","doi-asserted-by":"crossref","unstructured":"Trichopoulou A, Costacou T, Bamia C, Trichopoulou D: Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med\u2008348:2599\u2013608, 2003","DOI":"10.1056\/NEJMoa025039"},{"key":"2022031220155608600_R38","doi-asserted-by":"crossref","unstructured":"Estruch R, Martinez-Gonzalez MA, Corella D, Salas-Salvado J, Ruiz-Gutierrez V, Covas MI, PREDIMED Study Investigators: Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med\u2008145:1\u201311, 2006","DOI":"10.7326\/0003-4819-145-1-200607040-00004"},{"key":"2022031220155608600_R39","doi-asserted-by":"crossref","unstructured":"Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, Parker LM, Perri MG, Phillips L, Prentice RL, Robbins J, Rossouw JE, Sarto GE, Schatz IJ, Snetselaar LG, Stevens VJ, Tinker LF, Trevisan M, Vitolins MZ, Anderson GL, Assaf AR, Bassford T, Beresford SA, Black HR, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, Granek I, Greenland P, Hays J, Heber D, Heiss G, Hendrix SL, Hubbell FA, Johnson KC, Kotchen JM: Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA\u2008295:655\u2013666, 2006","DOI":"10.1001\/jama.295.6.655"},{"key":"2022031220155608600_R40","doi-asserted-by":"crossref","unstructured":"Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DE: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ\u2008316:823\u2013828, 1998","DOI":"10.1136\/bmj.316.7134.823"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/30\/5\/1241\/596931\/zdc00507001241.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/30\/5\/1241\/596931\/zdc00507001241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T22:06:09Z","timestamp":1647122769000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/30\/5\/1241\/29838\/Incidence-of-Coronary-Heart-Disease-in-Type-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc06-2558","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}